Research
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis
BMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a2313 (Published 14 November 2008) Cite this as: BMJ 2008;337:a2313
Related articles
- Editorial Published: 13 November 2008; BMJ 337 doi:10.1136/bmj.a2213
- Correction Published: 08 May 2009; BMJ 338 doi:10.1136/bmj.b1881
- Education And Debate Published: 07 July 2001; BMJ 323 doi:10.1136/bmj.323.7303.42
- Paper Published: 13 September 1997; BMJ 315 doi:10.1136/bmj.315.7109.629
- Education And Debate Published: 04 September 2003; BMJ 327 doi:10.1136/bmj.327.7414.557
- Research Published: 27 August 2009; BMJ 339 doi:10.1136/bmj.b3154
- Letter Published: 06 January 2009; BMJ 338 doi:10.1136/bmj.a3149
- Letter Published: 29 September 2009; BMJ 339 doi:10.1136/bmj.b3956
See more
- All ranitidine should be discarded, says US drug agencyBMJ April 06, 2020, 369 m1390; DOI: https://doi.org/10.1136/bmj.m1390
- Ranitidine: doctors should switch patients to alternative, says health departmentBMJ October 17, 2019, 367 l6087; DOI: https://doi.org/10.1136/bmj.l6087
- BEACON trial in colorectal cancer is “single worst reported,” says criticBMJ October 16, 2019, 367 l6057; DOI: https://doi.org/10.1136/bmj.l6057
- GSK recalls ranitidine products over potential carcinogen contaminationBMJ October 08, 2019, 367 l5933; DOI: https://doi.org/10.1136/bmj.l5933
- Bowel cancer: experts advise against routine testing for everyone over 50BMJ October 03, 2019, 367 l5829; DOI: https://doi.org/10.1136/bmj.l5829
Cited by...
- Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis
- Functional abdominal pain: what clinicians need to know
- Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis
- The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS
- Dietary and pharmacological treatment of abdominal pain in IBS
- Chronic constipation: Update on management
- Systemic exposure to menthol following administration of peppermint oil to paediatric patients
- Nonpharmacologic Treatment of Functional Abdominal Pain Disorders: A Systematic Review
- In irritable bowel syndrome, antispasmodics and antidepressants improve abdominal pain and global assessment and symptom scores, but there is no evidence for the effectiveness of bulking agents
- Two weeks of rifaximin relieves global symptoms and bloating in people with IBS without constipation
- First-choice therapy for dogs presenting with diarrhoea in clinical practice
- Bran's deleterious effects: much ado about nothing
- Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial
- Irritable bowel syndrome: Are complementary and alternative medicine treatments useful?
- Syndrome du colon irritable: Les traitements complementaires et de medecine douce sont-ils utiles?
- The problem of insoluble fibre in irritable bowel syndrome
- Why pills more than skills?
- Don't forget amitriptyline
- Fiber, Antispasmodic Agents, and Peppermint Oil for Irritable Bowel Syndrome
- Treatment of irritable bowel syndrome in primary care